Genomics in Cushing's Disease: The Dawn of a New Era Genomics in Cushing's Disease: The Dawn of a New Era
What can genomic biomarkers tell us about the development and recurrence of pituitary tumors in Cushing ' s disease?Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Consumer Health: Treating pituitary tumors
The pituitary is a small, bean-shaped gland at the base of your brain, behind your nose and between your ears. Despite its small size, the pituitary gland influences nearly every part of your body. The hormones it produces help regulate important functions, such as growth, blood pressure and reproduction. Pituitary tumors are abnormal growths that [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 8, 2021 Category: Databases & Libraries Source Type: news

Register for the Royal Society of Medicine's webinar series on genetics and endocrinology
The Royal Society of Medicine, in association with the Society for Endocrinology, are holding a three-part webinar series on genetics and endocrinology. This series will take place online on 4-6 May 2021. It will feature experts across both of these fields and provide an overview on a number of topics, including testing for genetic disorders, thyroid disorders, delayed puberty, pituitary tumours and Multiple Endocrine Neoplasia. Find out more and register for all 3 webinars by emailingevents@rsm.ac.uk. (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 20, 2021 Category: Endocrinology Source Type: news

Current Perspectives on Recurrent Pituitary Adenoma Current Perspectives on Recurrent Pituitary Adenoma
Find out more about the available treatment options for recurring pituitary tumors, and learn when revision surgery should be considered.Clinical Endocrinology (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 3, 2020 Category: Radiology Tags: Diabetes & Endocrinology Journal Article Source Type: news

New way to study pituitary tumors holds potential for better diagnoses and treatments
(Houston Methodist) Houston Methodist neurosurgeons are looking at a new way to classify pituitary tumors that could lead to more precise and accurate diagnosing for patients in the future. These tests also could have potential for better diagnoses in other brain tumors. The findings, published Jan. 28 in Scientific Reports, describe a new way to study the blood of pituitary adenoma patients to determine tumor type and whether they might respond to medical treatment rather than surgery. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 3, 2020 Category: International Medicine & Public Health Source Type: news

North by Northeast - a case of CNS Aspergilloma mistaken for pituitary tumour
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - December 12, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news

New dad celebrates first father's day after a brain tumor left him infertile
Derin Gebhardt, 37, from Roundup, Montana, was diagnosed in May 2017 with a pituitary tumor, which was causing a decrease in normal levels of sex hormones and behind his infertility. (Source: the Mail online | Health)
Source: the Mail online | Health - June 14, 2019 Category: Consumer Health News Source Type: news

Cushing's disease tumour detection enhanced by hormonal activation
Detecting pituitary tumours in Cushing's patients is enhanced by administration of corticotropin-releasing hormone, according to a study published inEndocrine.Cushing's Disease News (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 12, 2019 Category: Endocrinology Source Type: news

Cambridge drug developer Tiburio launches, targeting pituitary tumors with $31M
A Cambridge startup hoping to develop the first drug treatments to shrink dangerous tumors on the brain's pituitary gland launched Thursday with $31 million in funding. Tiburio Therapeutics Inc. was spun out of Cambridge orphan disease accelerator Cydan this week with the Series A funding from New Enterprise Associates, Longitude Capital and Alexandria Real Estate Equities Inc.'s (NYSE: ARE) venture arm, Alexandria Venture Investments. Ibsen, which moved its U.S. headquarters to Massachusetts last… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 3, 2019 Category: Biotechnology Source Type: news

Scientists discover intricacies of serotonin receptor crucial for better therapeutics
(University of North Carolina Health Care) For the first time, scientists have figured out why drugs that aim to treat Parkinson's disease, migraines, pituitary tumors, and obesity activate the serotonin receptor 5-HT2B to cause life-threatening heart problems. Published in Nature Structure& Molecular Biology, this research provides drug developers with much needed insights into serotonin receptors -- insights that should help scientists create safer more effective drugs, not just for the aforementioned conditions, but also depression, anxiety, and schizophrenia. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - August 20, 2018 Category: International Medicine & Public Health Source Type: news

New guideline for treatment of aggressive pituitary tumours
A new European clinical practice guideline for the treatment of aggressive pituitary tumours and carcinomas has been published in theEuropean Journal of Endocrinology.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 18, 2018 Category: Endocrinology Source Type: news

Pituitary Tumor Treatment
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 3, 2017 Category: General Medicine Source Type: news

NIH researchers find potential genetic cause of Cushing syndrome
Finding may lead to therapies that prevent pituitary tumor recurrence. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - June 1, 2017 Category: American Health Source Type: news

Dopamine agonists for pituitary tumours: to treat or not?
The benefits and risks of giving patients medical therapy after surgery to prevent regrowth of nonfunctioning pituitary adenomas was debated at the European Congress of Endocrinology 2017, with the final vote revealing a 50-50 split of opinion from the audience.Medscape (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 31, 2017 Category: Endocrinology Source Type: news

Dopamine Agonists for Pituitary Tumors: To Treat or Not? Dopamine Agonists for Pituitary Tumors: To Treat or Not?
A novel use of medical therapy soon after surgery for nonfunctioning pituitary adenomas was up for debate, with strong arguments for and against changing the standard of care.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 22, 2017 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news